V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 220004455 | 220001785 | 1.69 | 67.5 | Palliative (P) | 2018-01-20 | 2018-01-25 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026082 | CYTARABINE |
| 220004456 | 220010893 | 1.47 | 70.2 | Curative (C) | 2015-06-12 | 2015-06-26 | LI-1 TRIAL | null | N | 220026084 | TRIAL |
| 220004457 | 220010893 | 0 | null | Disease modification (D) | null | 2013-05-05 | Trial Unspecified | null | null | 220026084 | TRIAL |
| 220004458 | 220001786 | null | null | Palliative (P) | 2014-01-01 | 2014-01-03 | CYTARABINE | N | N | 220026088 | CYTARABINE |
| 220004459 | 220001786 | 0 | null | Curative (C) | 2017-08-17 | 2017-08-18 | AML17 TRIAL | Y | N | 220026088 | AML17 TRIAL |
| 220004460 | 220001786 | 1.57 | null | null | null | 2017-11-25 | Trial Unspecified | N | N | 220026088 | TRIAL |
| 220004461 | 220001786 | null | 107 | Curative (C) | 2017-05-19 | 2017-05-23 | AML17 TRIAL | 2 | N | 220026088 | AML17 TRIAL |
| 220004462 | 220001787 | null | null | Disease modification (D) | null | 2016-04-15 | Cytarabine Low Dose | null | null | 220026093 | CYTARABINE |
| 220004463 | 220001787 | null | 80.7 | null | 2017-03-08 | 2017-03-09 | Trial Unspecified | 1 | null | 220026093 | TRIAL |
| 220004466 | 220020270 | 1.57 | 66 | Curative (C) | null | 2013-02-07 | Trial Unspecified | Y | null | 220026106 | TRIAL |
| 220004467 | 220001788 | 1.6 | 58.4 | Curative (C) | 2016-04-12 | 2016-04-18 | LI-1 TRIAL | Y | N | 220026107 | TRIAL |
| 220004468 | 220001788 | 1.62 | 79 | Palliative (P) | 2017-04-20 | 2017-04-20 | Trial Unspecified | Y | N | 220026107 | TRIAL |
| 220004469 | 220015809 | 1.68 | 62.3 | Curative (C) | 2015-06-03 | 2015-06-10 | Trial Unspecified | 1 | null | 220026110 | TRIAL |
| 220004470 | 220001789 | 1.5 | null | Not known (9) | 2015-03-26 | 2015-03-26 | Trial Unspecified | Y | N | 220026111 | TRIAL |
| 220004471 | 220010897 | 1.61 | 70.6 | Curative (C) | 2013-11-03 | 2013-11-03 | AML17 TRIAL | N | N | 220026113 | AML17 TRIAL |
| 220004472 | 220010897 | 1.57 | 81 | null | 2016-02-03 | 2016-02-09 | AML17 TRIAL | 01 | N | 220026113 | AML17 TRIAL |
| 220004473 | 220010897 | null | null | Palliative (P) | 2016-04-07 | 2016-04-12 | Cytarabine low (10to20mg/m2) IV/SC | null | null | 220026113 | CYTARABINE |
| 220004475 | 220001791 | 0 | 0 | Palliative (P) | 2015-05-11 | 2015-05-12 | Trial Unspecified | N | N | 220026119 | TRIAL |
| 220004476 | 220001791 | null | 64.4 | Curative (C) | 2017-08-02 | 2017-08-02 | LI-1 TRIAL | 1 | null | 220026119 | TRIAL |
| 220004477 | 220001791 | 1.68 | 74.199 | Adjuvant (A) | 2015-11-19 | 2015-11-21 | AML17 TRIAL | 1 | N | 220026119 | AML17 TRIAL |
| 220004478 | 220001792 | 1.68 | 0 | Curative (C) | 2016-02-28 | 2016-03-01 | Cytarabine Low Dose | 2 | N | 220026127 | CYTARABINE |
| 220004479 | 220001792 | 1.68 | 81.6 | Curative (C) | 2013-06-28 | 2013-07-02 | Cytarabine Low Dose | 02 | null | 220026127 | CYTARABINE |
| 220004480 | 220001792 | 1.85 | null | Curative (C) | 2016-07-11 | 2016-07-12 | AML17 TRIAL | 02 | N | 220026127 | AML17 TRIAL |
| 220004481 | 220001792 | 0 | 0 | Palliative (P) | 2016-10-29 | 2016-10-30 | Cytarabine Low Dose | 2 | N | 220026127 | CYTARABINE |
| 220004482 | 220001792 | 1.8 | 90.7 | Curative (C) | 2015-10-04 | 2015-10-06 | AML17 TRIAL | 1 | N | 220026127 | AML17 TRIAL |
| 220004483 | 220001793 | null | 105 | null | 2016-11-01 | 2016-11-01 | CYTARABINE | 02 | null | 220026137 | CYTARABINE |
| 220004484 | 220001793 | 1.82 | null | null | null | 2016-01-07 | Cytarabine Low Dose | N | Y | 220026137 | CYTARABINE |
| 220004485 | 220015813 | 1.75 | 88.8 | Disease modification (D) | 2014-01-14 | 2014-01-15 | Trial Unspecified | Y | N | 220026144 | TRIAL |
| 220004486 | 220015813 | 1.82 | null | Curative (C) | 2013-08-09 | 2013-08-21 | AML17 TRIAL | N | N | 220026144 | AML17 TRIAL |
| 220004487 | 220015813 | 1.52 | 71 | null | 2013-09-26 | 2013-09-26 | Trial Unspecified | Y | N | 220026144 | TRIAL |
| 220004488 | 220015813 | 1.71 | 70.2 | Palliative (P) | null | 2015-03-02 | Cytarabine Low Dose | N | N | 220026144 | CYTARABINE |
| 220004489 | 220001794 | 1.74 | 75.4 | Palliative (P) | 2013-02-11 | 2013-02-13 | Cytarabine Low Dose | N | N | 220026151 | CYTARABINE |
| 220004490 | 220010901 | 0 | 0 | null | 2013-06-29 | 2013-06-30 | Cytarabine low (10to20mg/m2) IV/SC | Y | N | 220026154 | CYTARABINE |
| 220004491 | 220001795 | 1.92 | 68.8 | Curative (C) | 2016-09-30 | 2016-10-01 | AML17 TRIAL | 01 | N | 220026155 | AML17 TRIAL |
| 220004492 | 220001796 | 0 | null | Curative (C) | 2014-04-24 | 2014-04-24 | Trial Unspecified | 1 | N | 220026157 | TRIAL |
| 220004493 | 220001796 | 1.79 | 78.9 | Disease modification (D) | 2014-08-02 | 2014-08-02 | Cytarabine Low Dose | N | N | 220026157 | CYTARABINE |
| 220004494 | 220001796 | 1.68 | 84.6 | Palliative (P) | 2016-02-19 | 2016-02-20 | Cytarabine Low Dose | N | Y | 220026157 | CYTARABINE |
| 220004497 | 220001797 | 1.83 | 80.9 | Curative (C) | 2015-09-23 | 2015-11-02 | LI-1 TRIAL | Y | N | 220026172 | TRIAL |
| 220004498 | 220010903 | null | 67.3 | Curative (C) | 2015-10-25 | 2015-10-26 | Trial Unspecified | Y | N | 220026173 | TRIAL |
| 220004499 | 220010903 | 1.58 | 86 | null | 2015-09-06 | 2015-09-06 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026173 | CYTARABINE |
| 220004500 | 220010903 | 1.73 | 71.3 | Palliative (P) | 2015-10-14 | 2015-10-21 | Cytarabine low (10to20mg/m2) IV/SC | N | N | 220026173 | CYTARABINE |
| 220004501 | 220001798 | 1.63 | null | Curative (C) | 2013-01-08 | 2013-01-08 | AML17 TRIAL | 02 | N | 220026177 | AML17 TRIAL |
| 220004502 | 220001798 | null | 72.7 | Not known (9) | 2015-11-19 | 2015-11-19 | AML17 TRIAL | 01 | N | 220026177 | AML17 TRIAL |
| 220004503 | 220001798 | 1.78 | 65.8 | null | 2016-03-02 | 2016-03-02 | Trial Unspecified | Y | N | 220026177 | TRIAL |
| 220004504 | 220001798 | 1.74 | 81.8 | Curative (C) | 2015-11-07 | 2015-11-07 | AML17 TRIAL | Y | N | 220026177 | AML17 TRIAL |
| 220004505 | 220020274 | 1.7 | null | null | null | 2015-11-08 | Cytarabine Low Dose | null | null | 220026181 | CYTARABINE |
| 220004506 | 220020274 | 1.63 | 58.4 | Curative (C) | 2015-02-23 | 2015-02-23 | AML17 TRIAL | 01 | null | 220026181 | AML17 TRIAL |
| 220004507 | 220001799 | 0 | 69.4 | Curative (C) | 2016-06-21 | 2016-06-23 | Trial Unspecified | Y | N | 220026185 | TRIAL |
| 220004508 | 220010905 | null | null | null | 2013-09-28 | 2013-10-02 | Cytarabine Low Dose | N | N | 220026191 | CYTARABINE |
| 220004509 | 220001800 | null | null | Curative (C) | 2017-06-08 | 2017-06-12 | Trial Unspecified | 01 | null | 220026193 | TRIAL |